open trial high-dosage antioxidants early Parkinson disease High dosages tocopherol ascorbate patients early Parkinson disease preliminary open-labeled trial eventual double-blind study antioxidants test endogenous toxin hypothesis etiology Parkinson disease primary endpoint trial need patients levodopa time levodopa necessary treated patients group patients antioxidants time levodopa necessary group antioxidants results pilot study progression Parkinson disease administration antioxidants large multicenter clinical trial North America tocopherol deprenyl potential results 